Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$25.24
+1.0%
$26.61
$18.89
$30.46
N/A0.87360,909 shs109,201 shs
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$16.33
-1.0%
$13.62
$10.06
$17.67
$1.42B1.21751,068 shs191,949 shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$2.28
+4.8%
$2.02
$1.35
$3.27
$98.40M0.59530,380 shs259,975 shs
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$0.00
C$0.12
C$2.50
C$21.27MN/A68,686 shs239,293 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+0.51%+3.16%-6.01%-16.21%+30.65%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
+3.06%+12.08%+31.11%+8.75%+52.88%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-3.98%+9.60%+3.83%+11.28%-21.66%
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
3.2102 of 5 stars
2.01.02.50.01.10.05.0
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.0335 of 5 stars
1.35.00.00.03.31.71.3
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
3.2825 of 5 stars
3.35.00.00.03.21.70.6
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
2.00
Hold$27.8010.14% Upside
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.57
Moderate Buy$16.752.60% Upside
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
2.50
Moderate Buy$3.1538.46% Upside
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest MD, QIPT, FMS, and TRL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/19/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$1.70 ➝ $2.30
8/18/2025
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/14/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$16.00 ➝ $16.50
8/12/2025
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight
8/11/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$20.63BN/A$4.95 per share5.10$29.08 per shareN/A
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$2.01B0.71$1.80 per share9.07$9.57 per share1.71
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$238.38M0.41$1.02 per share2.22$2.36 per share0.96
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$407.64M0.00N/A0.77C$0.38 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$582.08M$1.2220.6813.150.583.39%6.75%3.13%11/4/2025 (Estimated)
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-$99.07M$1.2912.6612.18N/A5.66%18.94%7.10%11/7/2025 (Estimated)
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.24N/AN/AN/A-4.30%-9.78%-4.23%N/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/AC$6.340.04N/A0.86N/AN/AN/AN/A

Latest MD, QIPT, FMS, and TRL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025Q3 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.03-$0.07-$0.10-$0.07$80.37 million$58.30 million
8/5/2025Q2 2025
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.50$0.52+$0.02$0.44$5.00 billion$5.54 billion
8/5/2025Q2 2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.42$0.53+$0.11$0.46$464.37 million$468.84 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.572.26%N/A46.72%N/A
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$1.31704.17%N/A20.69%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.44
1.44
1.08
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.70
1.80
1.80
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.71
1.15
0.75
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/A
5.92
3.87
CompanyEmployeesShares OutstandingFree FloatOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,384N/AN/AOptionable
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
4,30587.08 million86.30 millionOptionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
1,20043.44 million37.62 millionOptionable
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
70,00088.63 millionN/ANot Optionable

Recent News About These Companies

Trilogy International Partners Inc TRL.H
Trilogy International Ltd (TIL)
Trilogy International Partners GAAP EPS of -$0.03

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$25.24 +0.26 (+1.04%)
As of 02:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Pediatrix Medical Group stock logo

Pediatrix Medical Group NYSE:MD

$16.32 -0.17 (-1.00%)
As of 02:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$2.28 +0.11 (+4.84%)
As of 02:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Trilogy International Partners stock logo

Trilogy International Partners TSE:TRL

Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services in New Zealand, Bolivia, and internationally. It offers prepaid and postpaid payment plans, including local, international long distance, and roaming services to customers and international visitors roaming on its networks. The company also provides fixed broadband communications to residential and enterprise customers, as well as a range of mobile and fixed line services in New Zealand and Australia; and fixed public telephony and wireless broadband services in Bolivia. As of December 31, 2021, it had a distribution network of approximately 13 company owned stores, 170 dealers, and 8,300 other dealer points of presence in Bolivia; and a distribution network of approximately 20 company owned retail stores, 40 independent dealers, and 2,500 points of sale through national retail chains and grocery stores in New Zealand. The company's services cover an aggregate population of 16.8 million users. It also provides services through its online self-service store in New Zealand; and operates under the Viva brand name in Bolivia. Trilogy International Partners Inc. was founded in 1982 and is headquartered in Bellevue, Washington.